Quốc gia: Vương quốc Anh
Ngôn ngữ: Tiếng Anh
Nguồn: MHRA (Medicines & Healthcare Products Regulatory Agency)
Clarithromycin
Teva UK Ltd
J01FA09
Clarithromycin
500mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010500; GTIN: 5017007025504
PACKAGE LEAFLET: INFORMATION FOR THE USER CLARITHROMYCIN 250 MG AND 500 MG FILM-COATED TABLETS (Clarithromycin) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have further questions, ask your doctor or your pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Clarithromycin tablets are and what they are used for 2. What you need to know before you take Clarithromycin tablets 3. How to take Clarithromycin tablets 4. Possible side effects 5. How to store Clarithromycin tablets 6. Contents of the pack and other information 1. WHAT CLARITHROMYCIN TABLETS ARE AND WHAT THEY ARE USED FOR Each Clarithromycin tablet contains 250 mg of the active ingredient clarithromycin Each Clarithromycin tablet contains 500 mg of the active ingredient clarithromycin. Clarithromycin belongs to a group of medicines called macrolide antibiotics. Antibiotics stop the growth of bacteria (bugs) which cause infections. Clarithromycin tablets are used to treat infections such as: • Chest infections such as bronchitis and pneumonia • Throat and sinus infections • Skin and tissue infections • _Helicobacter pylori_ infection associated with duodenal ulcer Clarithromycin tablets are indicated in adults and children 12 years and older. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CLARITHROMYCIN TABLETS DO NOT TAKE CLARITHROMYCIN TABLETS IF YOU: • know that you are ALLERGIC to clarithromycin, other macrolide antibiotics such as erythromycin or azithromycin, or any of the other ingredients in the tablets (see section 6). • are taking medicines called ergot alkaloid tablets (e.g. ergotamine or dihydroergotamine) or use ergo Đọc toàn bộ tài liệu
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Clarithromycin 500mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains 500mg Clarithromycin For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film-coated tablet light yellow, film-coated, oval shaped tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Clarithromycin film-coated tablets are indicated in adults and adolescents 12 years and older for the treatment of the following bacterial infections, when caused by clarithromycin susceptible bacteria(see section 4.4 and 5.1). • Acute bacterial exacerbation of chronic bronchitis • Mild to moderate community acquired pneumonia • Acute bacterial sinusitis • Bacterial pharyngitis • Skin infections and soft tissue infections of mild to moderate severity, such as folliculitis, cellulitis and erysipelas Clarithromycin film-coated tablets can also be used in appropriate combination with antibacterial therapeutic regimens and an appropriate ulcer healing agent for the eradication of _Helicobacter pylori_ in patients with _Helicobacter pylori_ associated ulcers (see section 4.2). Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The dosage of Clarithromycin film-coated Tablets depends on the clinical condition of the patient and has to be defined in any case by the physician. _Children older than 12 years and adults: _ • Standard dosage: The usual dose is 250 mg twice daily. • High dosage treatment (severe infections): The usual dose may be increased to 500 mg twice daily in severe infections. • Clinical trials have been conducted using clarithromycin pediatric suspension in children 6 months to 12 years of age. Therefore, children under 12 years of age should use clarithromycin pediatric suspension (granules for oral suspension). _Elimination of Helicobacter pylori in adults: _ In patients with gastro-duodenal ulcers due to H. py Đọc toàn bộ tài liệu